Overview
Skin cancer biomarkers are molecules or substances that can indicate the presence of skin cancer. They can help identify a person's risk of developing the disease, enabling early diagnosis and treatment. The most commonly used biomarkers for skin cancer include melanoma antigens and C-reactive proteins. Melanoma antigens are proteins that are present in abnormally high levels in melanoma cells, while C-reactive proteins are generated in response to inflammation in the body caused by cancer. Detecting these biomarkers can allow doctors to diagnose skin cancer earlier, leading to better outcomes for patients. The use of these biomarkers also allows physicians to monitor a patient's progress as they receive treatment.
Research published in this journal
No peer-reviewed research on this exact topic has been published in Skin Cancer Epidemiology yet. Browse the journal →